RN7SL128P

Across TCGA pan-cancer cohorts, RN7SL128P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RN7SL128P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL128P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL128P is over-expressed in tumor, although a few such as STAD and LUAD show the opposite, repressed pattern.

COAD, BRCA, and KIRP are the cancer types where RN7SL128P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL128P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.411	.011	6	view →
BRCA	All	II,III,IV	+0.394	<.001	4	view →
KIRP	Female	II,III,IV	+0.522	.016	2	view →
STAD	Male	IV	−0.835	.022	1	view →
LUAD	All	III,IV	−0.417	.032	1	view →
THCA	Male	All	−0.240	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RN7SL128P–COAD

Open the COAD breakdown →